Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2009-01-31
2009-12-08
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S058000, C536S120000, C536S123100
Reexamination Certificate
active
07629331
ABSTRACT:
A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAECD. In particular, the SAE-CD composition possesses an advantageous physicochemical and morphological property profile such that it can be tailored to particular uses. The SAE-CD composition of the invention has improved flow and dissolution performance as compared to known compositions of SAE-CD.
REFERENCES:
patent: 3426011 (1969-02-01), Parmerter et al.
patent: 4920214 (1990-04-01), Friedman
patent: 4946654 (1990-08-01), Uhlemann et al.
patent: 5134127 (1992-07-01), Stella et al.
patent: 5376645 (1994-12-01), Stella et al.
patent: 5674854 (1997-10-01), Bodley et al.
patent: 5756484 (1998-05-01), Fuertes et al.
patent: 5874418 (1999-02-01), Stella et al.
patent: 5935940 (1999-08-01), Weisz
patent: 5935941 (1999-08-01), Pitha
patent: 6046177 (2000-04-01), Stella et al.
patent: 6153746 (2000-11-01), Shah et al.
patent: 6555139 (2003-04-01), Sharma
patent: 7034013 (2006-04-01), Thompson et al.
patent: 2003/0028014 (2003-02-01), Sikorski et al.
patent: 2003/0065167 (2003-04-01), Lis et al.
patent: 2004/0234479 (2004-11-01), Schleifenbaum et al.
patent: 2005/0164986 (2005-07-01), Mosher et al.
patent: 2006/0128654 (2006-06-01), Tang et al.
patent: 2006/0194762 (2006-08-01), Reer et al.
patent: 2007/0175472 (2007-08-01), Pipkin et al.
patent: 2008/0075784 (2008-03-01), Friesen et al.
patent: 2009/0011037 (2009-01-01), Pipkin et al.
patent: 0 392 608 (1995-06-01), None
Stella, V.J., “SBE7-β-CD, A New, Novel and Safe Polyanionic β-Cyclodextrin Derivative: Characterization and Biomedical Applications,” inProceedings of the Eighth International Symposium on Cyclodextrins, Budapest, Hungary, Mar. 31-Apr. 2, 1996, Szejtli, J., and Szente, L., eds., Kluwer Academic Publishers, Dordrecht, Netherlands, pp. 471-476 (1996).
Szente, L., and Szejtli, J., “Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development,”Adv. Drug Deliv. Rev.36:17-28, Elsevier Science Publishers, B.V. (1999).
Co-pending U.S. Appl. No. 12/404,174, inventor Antle, filed Mar. 13, 2009 (Not Yet Published).
International Search Report for International Application No. PCT/US2005/38933, filed on Oct. 26, 2005, mailed on Aug. 3, 2006, U.S. Patent Office, Alexandria, Virginia.
Hecker Douglas B.
Mosher Gerold L.
Pipkin James D.
CyDex Pharmaceuticals, Inc.
Jiang Shaojia Anna
Olson Eric S
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Sulfoalkyl ether cyclodextrin compositions and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfoalkyl ether cyclodextrin compositions and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfoalkyl ether cyclodextrin compositions and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4128553